HER2-Negative Breast Cancer Terminated Phase 2 Trials for Capecitabine (DB01101)

Indication	Status	Phase
DBCOND0072181 (HER2-Negative Breast Cancer)	Terminated	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00194792	Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer	Treatment	Capecitabine (DB01101) Exemestane (DB00990) Methotrexate (DB00563) Paclitaxel (DB01229) Triptorelin (DB06825) Vinorelbine (DB00361)